After Kenya, Ethiopia and Vietnam are the next in line for the access programme, and Novartis hopes to eventually extend it to at least 30 countries. To help guide the roll-out, Novartis is ...
and Vietnam. Since 2020, the global SMA treatment landscape has progressed, with three treatments now approved, according to Novartis. Along with Zolgensma – which made its debut in 2019 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback